APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Drug Delivery Systems

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.

Selected research

Market Analysis & Forecast

Global Microneedle Drug Delivery Systems Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchMicroneedle Drug Delivery Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Drug Delivery Systems Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Microneedle Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Drug Delivery Systems Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Drug Delivery Systems Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.

Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

Read the full market overview

The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.

Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.

3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Includes

This report presents an overview of global market for Microneedle Drug Delivery Systems, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microneedle Drug Delivery Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Microneedle Drug Delivery Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microneedle Drug Delivery Systems revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microneedle Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microneedle Drug Delivery Systems revenue, projected growth trends, production technology, application and end-user industry.

Microneedle Drug Delivery Systems Segment by Company

KINDEVA

Zosano Pharma

Becton-Dickinson(BD)Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect, Inc

Vaxxas

Lohmann Therapie-Systeme AG

Microneedle Drug Delivery Systems Segment by Type

Hollow Microneedle Technology

Solid Microneedle Technology

Dissolving Microneedles Technology

Microneedle Drug Delivery Systems Segment by Application

Drug Delivery

Vaccine Delivery

Microneedle Drug Delivery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microneedle Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microneedle Drug Delivery Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microneedle Drug Delivery Systems revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hollow Microneedle Technology Major Player Table 3. Solid Microneedle Technology Major Player Table 4. Dissolving Microneedles Technology Major Player Table 5. Global Microneedle Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Delivery Major Player Table 7. Vaccine Delivery Major Player Table 8. Microneedle Drug Delivery Systems Industry Trends Table 9. Microneedle Drug Delivery Systems Industry Drivers Table 10. Microneedle Drug Delivery Systems Industry Opportunities and Challenges Table 11. Microneedle Drug Delivery Systems Industry Restraints Table 12. Global Microneedle Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Microneedle Drug Delivery Systems Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Microneedle Drug Delivery Systems Market Share by Region (2021-2026) Table 15. Global Microneedle Drug Delivery Systems Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Microneedle Drug Delivery Systems Market Share by Region (2027-2032) Table 17. Global Microneedle Drug Delivery Systems Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2021-2026) Table 19. Global Microneedle Drug Delivery Systems Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Microneedle Drug Delivery Systems Key Players Headquarters & Area Served Table 21. Global Microneedle Drug Delivery Systems Players, Product Type & Application Table 22. Global Microneedle Drug Delivery Systems Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Microneedle Drug Delivery Systems by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Microneedle Drug Delivery Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2021-2026) Table 29. Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2027-2032) Table 30. Global Microneedle Drug Delivery Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2021-2026) Table 34. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2027-2032) Table 35. KINDEVA Company Information Table 36. KINDEVA Business Overview Table 37. KINDEVA Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. KINDEVA Microneedle Drug Delivery Systems Product Portfolio Table 39. KINDEVA Recent Development Table 40. Zosano Pharma Company Information Table 41. Zosano Pharma Business Overview Table 42. Zosano Pharma Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zosano Pharma Microneedle Drug Delivery Systems Product Portfolio Table 44. Zosano Pharma Recent Development Table 45. Becton-Dickinson(BD)Technologies Company Information Table 46. Becton-Dickinson(BD)Technologies Business Overview Table 47. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Portfolio Table 49. Becton-Dickinson(BD)Technologies Recent Development Table 50. Nanopass Technologies Company Information Table 51. Nanopass Technologies Business Overview Table 52. Nanopass Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Nanopass Technologies Microneedle Drug Delivery Systems Product Portfolio Table 54. Nanopass Technologies Recent Development Table 55. Corium Company Information Table 56. Corium Business Overview Table 57. Corium Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Corium Microneedle Drug Delivery Systems Product Portfolio Table 59. Corium Recent Development Table 60. Valeritas Company Information Table 61. Valeritas Business Overview Table 62. Valeritas Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Valeritas Microneedle Drug Delivery Systems Product Portfolio Table 64. Valeritas Recent Development Table 65. Nitto Company Information Table 66. Nitto Business Overview Table 67. Nitto Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nitto Microneedle Drug Delivery Systems Product Portfolio Table 69. Nitto Recent Development Table 70. Microdermics Company Information Table 71. Microdermics Business Overview Table 72. Microdermics Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Microdermics Microneedle Drug Delivery Systems Product Portfolio Table 74. Microdermics Recent Development Table 75. TheraJect, Inc Company Information Table 76. TheraJect, Inc Business Overview Table 77. TheraJect, Inc Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. TheraJect, Inc Microneedle Drug Delivery Systems Product Portfolio Table 79. TheraJect, Inc Recent Development Table 80. Vaxxas Company Information Table 81. Vaxxas Business Overview Table 82. Vaxxas Microneedle Drug Delivery Systems Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Vaxxas Microneedle Drug Delivery Systems Product Portfolio Table 84. Vaxxas Recent Development Table 85. Lohmann Therapie-Systeme AG Company Information Table 86. Lohmann Therapie-Systeme AG Business Overview Table 87. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 88. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Portfolio Table 89. Lohmann Therapie-Systeme AG Recent Development Table 90. North America Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Microneedle Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Microneedle Drug Delivery Systems Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Microneedle Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Microneedle Drug Delivery Systems Revenue by Country (US$ Million) & (2027-2032) Table 104. China Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 105. China Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 106. China Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 107. China Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Microneedle Drug Delivery Systems Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Microneedle Drug Delivery Systems Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Microneedle Drug Delivery Systems Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Microneedle Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Microneedle Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Microneedle Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Microneedle Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Microneedle Drug Delivery Systems Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Microneedle Drug Delivery Systems Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Microneedle Drug Delivery Systems Image Figure 2. Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hollow Microneedle Technology Image Figure 5. Solid Microneedle Technology Image Figure 6. Dissolving Microneedles Technology Image Figure 7. Global Microneedle Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Microneedle Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Delivery Image Figure 10. Vaccine Delivery Image Figure 11. Global Microneedle Drug Delivery Systems Market Size (US$ Million) & (2021-2032) Figure 12. Global Microneedle Drug Delivery Systems Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Microneedle Drug Delivery Systems Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Microneedle Drug Delivery Systems Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Microneedle Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microneedle Drug Delivery Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2021-2032) Figure 19. Global Microneedle Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2021-2032) Figure 22. North America Microneedle Drug Delivery Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 24. North America Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 25. North America Microneedle Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 26. United States Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Microneedle Drug Delivery Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 31. Europe Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 32. Europe Microneedle Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 33. Germany Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Microneedle Drug Delivery Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 43. China Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 44. Asia Microneedle Drug Delivery Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 46. Asia Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 47. Asia Microneedle Drug Delivery Systems Revenue Share by Region (2021-2032) Figure 48. Japan Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Microneedle Drug Delivery Systems Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 56. SAMEA Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 57. SAMEA Microneedle Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 58. Brazil Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Microneedle Drug Delivery Systems Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology
Applications
  • Drug Delivery
  • Vaccine Delivery
Companies covered
  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microneedle Drug Delivery Systems Market by Type
  3. 1.2.1 Global Microneedle Drug Delivery Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hollow Microneedle Technology
  5. 1.2.3 Solid Microneedle Technology
  6. 1.2.4 Dissolving Microneedles Technology
  7. 1.3 Microneedle Drug Delivery Systems Market by Application
  8. 1.3.1 Global Microneedle Drug Delivery Systems Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Delivery
  10. 1.3.3 Vaccine Delivery
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Microneedle Drug Delivery Systems Market Dynamics
  1. 2.1 Microneedle Drug Delivery Systems Industry Trends
  2. 2.2 Microneedle Drug Delivery Systems Industry Drivers
  3. 2.3 Microneedle Drug Delivery Systems Industry Opportunities and Challenges
  4. 2.4 Microneedle Drug Delivery Systems Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microneedle Drug Delivery Systems Market Perspective (2021-2032)
  2. 3.2 Global Microneedle Drug Delivery Systems Growth Trends by Region
  3. 3.2.1 Global Microneedle Drug Delivery Systems Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microneedle Drug Delivery Systems Market Size by Region (2021-2026)
  5. 3.2.3 Global Microneedle Drug Delivery Systems Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microneedle Drug Delivery Systems Revenue by Players
  2. 4.1.1 Global Microneedle Drug Delivery Systems Revenue by Players (2021-2026)
  3. 4.1.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microneedle Drug Delivery Systems Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microneedle Drug Delivery Systems Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microneedle Drug Delivery Systems Key Players Headquarters & Area Served
  7. 4.4 Global Microneedle Drug Delivery Systems Players, Product Type & Application
  8. 4.5 Global Microneedle Drug Delivery Systems Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microneedle Drug Delivery Systems Market CR5 and HHI
  11. 4.6.3 2025 Microneedle Drug Delivery Systems Tier 1, Tier 2, and Tier 3
5 Microneedle Drug Delivery Systems Market Size by Type
  1. 5.1 Global Microneedle Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 5.3 Global Microneedle Drug Delivery Systems Revenue Market Share by Type (2021-2032)
6 Microneedle Drug Delivery Systems Market Size by Application
  1. 6.1 Global Microneedle Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  3. 6.3 Global Microneedle Drug Delivery Systems Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 KINDEVA
  2. 7.1.1 KINDEVA Company Information
  3. 7.1.2 KINDEVA Business Overview
  4. 7.1.3 KINDEVA Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  5. 7.1.4 KINDEVA Microneedle Drug Delivery Systems Product Portfolio
  6. 7.1.5 KINDEVA Recent Developments
  7. 7.2 Zosano Pharma
  8. 7.2.1 Zosano Pharma Company Information
  9. 7.2.2 Zosano Pharma Business Overview
  10. 7.2.3 Zosano Pharma Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zosano Pharma Microneedle Drug Delivery Systems Product Portfolio
  12. 7.2.5 Zosano Pharma Recent Developments
  13. 7.3 Becton-Dickinson(BD)Technologies
  14. 7.3.1 Becton-Dickinson(BD)Technologies Company Information
  15. 7.3.2 Becton-Dickinson(BD)Technologies Business Overview
  16. 7.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Portfolio
  18. 7.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  19. 7.4 Nanopass Technologies
  20. 7.4.1 Nanopass Technologies Company Information
  21. 7.4.2 Nanopass Technologies Business Overview
  22. 7.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Product Portfolio
  24. 7.4.5 Nanopass Technologies Recent Developments
  25. 7.5 Corium
  26. 7.5.1 Corium Company Information
  27. 7.5.2 Corium Business Overview
  28. 7.5.3 Corium Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Corium Microneedle Drug Delivery Systems Product Portfolio
  30. 7.5.5 Corium Recent Developments
  31. 7.6 Valeritas
  32. 7.6.1 Valeritas Company Information
  33. 7.6.2 Valeritas Business Overview
  34. 7.6.3 Valeritas Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Valeritas Microneedle Drug Delivery Systems Product Portfolio
  36. 7.6.5 Valeritas Recent Developments
  37. 7.7 Nitto
  38. 7.7.1 Nitto Company Information
  39. 7.7.2 Nitto Business Overview
  40. 7.7.3 Nitto Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nitto Microneedle Drug Delivery Systems Product Portfolio
  42. 7.7.5 Nitto Recent Developments
  43. 7.8 Microdermics
  44. 7.8.1 Microdermics Company Information
  45. 7.8.2 Microdermics Business Overview
  46. 7.8.3 Microdermics Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Microdermics Microneedle Drug Delivery Systems Product Portfolio
  48. 7.8.5 Microdermics Recent Developments
  49. 7.9 TheraJect, Inc
  50. 7.9.1 TheraJect, Inc Company Information
  51. 7.9.2 TheraJect, Inc Business Overview
  52. 7.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  53. 7.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Product Portfolio
  54. 7.9.5 TheraJect, Inc Recent Developments
  55. 7.10 Vaxxas
  56. 7.10.1 Vaxxas Company Information
  57. 7.10.2 Vaxxas Business Overview
  58. 7.10.3 Vaxxas Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Vaxxas Microneedle Drug Delivery Systems Product Portfolio
  60. 7.10.5 Vaxxas Recent Developments
  61. 7.11 Lohmann Therapie-Systeme AG
  62. 7.11.1 Lohmann Therapie-Systeme AG Company Information
  63. 7.11.2 Lohmann Therapie-Systeme AG Business Overview
  64. 7.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Portfolio
  66. 7.11.5 Lohmann Therapie-Systeme AG Recent Developments
8 North America
  1. 8.1 North America Microneedle Drug Delivery Systems Revenue (2021-2032)
  2. 8.2 North America Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 8.2.1 North America Microneedle Drug Delivery Systems Revenue by Type (2021-2026)
  4. 8.2.2 North America Microneedle Drug Delivery Systems Revenue by Type (2027-2032)
  5. 8.3 North America Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032)
  6. 8.4 North America Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  7. 8.4.1 North America Microneedle Drug Delivery Systems Revenue by Application (2021-2026)
  8. 8.4.2 North America Microneedle Drug Delivery Systems Revenue by Application (2027-2032)
  9. 8.5 North America Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032)
  10. 8.6 North America Microneedle Drug Delivery Systems Revenue by Country
  11. 8.6.1 North America Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microneedle Drug Delivery Systems Revenue by Country (2021-2026)
  13. 8.6.3 North America Microneedle Drug Delivery Systems Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microneedle Drug Delivery Systems Revenue (2021-2032)
  2. 9.2 Europe Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microneedle Drug Delivery Systems Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microneedle Drug Delivery Systems Revenue by Type (2027-2032)
  5. 9.3 Europe Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microneedle Drug Delivery Systems Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microneedle Drug Delivery Systems Revenue by Application (2027-2032)
  9. 9.5 Europe Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microneedle Drug Delivery Systems Revenue by Country
  11. 9.6.1 Europe Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microneedle Drug Delivery Systems Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microneedle Drug Delivery Systems Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microneedle Drug Delivery Systems Revenue (2021-2032)
  2. 10.2 China Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 10.2.1 China Microneedle Drug Delivery Systems Revenue by Type (2021-2026)
  4. 10.2.2 China Microneedle Drug Delivery Systems Revenue by Type (2027-2032)
  5. 10.3 China Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032)
  6. 10.4 China Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  7. 10.4.1 China Microneedle Drug Delivery Systems Revenue by Application (2021-2026)
  8. 10.4.2 China Microneedle Drug Delivery Systems Revenue by Application (2027-2032)
  9. 10.5 China Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microneedle Drug Delivery Systems Revenue (2021-2032)
  2. 11.2 Asia Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microneedle Drug Delivery Systems Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microneedle Drug Delivery Systems Revenue by Type (2027-2032)
  5. 11.3 Asia Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microneedle Drug Delivery Systems Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microneedle Drug Delivery Systems Revenue by Application (2027-2032)
  9. 11.5 Asia Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microneedle Drug Delivery Systems Revenue by Country
  11. 11.6.1 Asia Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microneedle Drug Delivery Systems Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microneedle Drug Delivery Systems Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microneedle Drug Delivery Systems Revenue (2021-2032)
  2. 12.2 SAMEA Microneedle Drug Delivery Systems Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microneedle Drug Delivery Systems Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microneedle Drug Delivery Systems Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microneedle Drug Delivery Systems Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microneedle Drug Delivery Systems Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microneedle Drug Delivery Systems Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microneedle Drug Delivery Systems Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microneedle Drug Delivery Systems Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microneedle Drug Delivery Systems Revenue by Country
  11. 12.6.1 SAMEA Microneedle Drug Delivery Systems Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microneedle Drug Delivery Systems Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microneedle Drug Delivery Systems Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst